Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userRAId DbS: A Mass-Spectrometry Based Peptide Identification Web Server with Knowledge Integration
145
0
0.0
(
0
)
Ask ChatGPT about the research
No Arabic abstract
Summary: In anticipation of the individualized proteomics era and the need to integrate knowledge from disease studies, we have augmented our peptide identification software RAId DbS to take into account annotated single amino acid polymorphisms, post-translational modifications, and their documented disease associations while analyzing a tandem mass spectrum. To facilitate new discoveries, RAId DbS allows users to conduct searches permitting novel polymorphisms. Availability: The webserver link is http://www.ncbi.nlm.nih.gov/ /CBBResearch/qmbp/raid dbs/index.html. The relevant databases and binaries of RAId DbS for Linux, Windows, and Mac OS X are available from the same web page. Contact: [email protected]
rate research
Read More
Motivation: Assigning statistical significance accurately has become increasingly important as meta data of many types, often assembled in hierarchies, are constructed and combined for further biological analyses. Statistical inaccuracy of meta data at any level may propagate to downstream analyses, undermining the validity of scientific conclusions thus drawn. From the perspective of mass spectrometry based proteomics, even though accurate statistics for peptide identification can now be achieved, accurate protein level statistics remain challenging. Results: We have constructed a protein ID method that combines peptide evidences of a candidate protein based on a rigorous formula derived earlier; in this formula the database $P$-value of every peptide is weighted, prior to the final combination, according to the number of proteins it maps to. We have also shown that this protein ID method provides accurate protein level $E$-value, eliminating the need of using empirical post-processing methods for type-I error control. Using a known protein mixture, we find that this protein ID method, when combined with the Soric formula, yields accurate values for the proportion of false discoveries. In terms of retrieval efficacy, the results from our method are comparable with other methods tested. Availability: The source code, implemented in C++ on a linux system, is available for download at ftp://ftp.ncbi.nlm.nih.gov/pub/qmbp/qmbp_ms/RAId/RAId_Linux_64Bit
The mechanism by which silver staining of proteins in polyacrylamide gels interferes with mass spectrometry of peptides produced by proteolysis has been investigated. It was demonstrated that this interference increases with time between silver staining and gel processing, although the silver image is constant. This suggested an important role of the formaldehyde used in silver staining development in this interference process. Consequently, a formaldehyde-free staining protocol has been devised, using carbohydrazide as the developing agent. This protocol showed much increased peptide coverage and retained the sensitivity of silver staining. These results were however obtained at the expense of an increased background in the stained gels and of a reduced staining homogeneity.
Metaproteomics are becoming widely used in microbiome research for gaining insights into the functional state of the microbial community. Current metaproteomics studies are generally based on high-throughput tandem mass spectrometry (MS/MS) coupled with liquid chromatography. The identification of peptides and proteins from MS data involves the computational procedure of searching MS/MS spectra against a predefined protein sequence database and assigning top-scored peptides to spectra. Existing computational tools are still far from being able to extract all the information out of large MS/MS datasets acquired from metaproteome samples. In this paper, we proposed a deep-learning-based algorithm, called DeepFilter, for improving the rate of confident peptide identifications from a collection of tandem mass spectra. Compared with other post-processing tools, including Percolator, Q-ranker, PeptideProphet, and Iprophet, DeepFilter identified 20% and 10% more peptide-spectrum-matches and proteins, respectively, on marine microbial and soil microbial metaproteome samples with false discovery rate at 1%.
We provide a complete thermodynamic solution of a 1D hopping model in the presence of a random potential by obtaining the density of states. Since the partition function is related to the density of states by a Laplace transform, the density of states determines completely the thermodynamic behavior of the system. We have also shown that the transfer matrix technique, or the so-called dynamic programming, used to obtain the density of states in the 1D hopping model may be generalized to tackle a long-standing problem in statistical significance assessment for one of the most important proteomic tasks - peptide sequencing using tandem mass spectrometry data.
An unsolved challenge in the development of antigen specific immunotherapies is determining the optimal antigens to target. Comprehension of antigen-MHC binding is paramount towards achieving this goal. Here, we present CASTELO, a combined machine learning-molecular dynamics (ML-MD) approach to design novel antigens of increased MHC binding affinity for a Type 1 diabetes (T1D)-implicated system. We build upon a small molecule lead optimization algorithm by training a convolutional variational autoencoder (CVAE) on MD trajectories of 48 different systems across 4 antigens and 4 HLA serotypes. We develop several new machine learning metrics including a structure-based anchor residue classification model as well as cluster comparison scores. ML-MD predictions agree well with experimental binding results and free energy perturbation-predicted binding affinities. Moreover, ML-MD metrics are independent of traditional MD stability metrics such as contact area and RMSF, which do not reflect binding affinity data. Our work supports the role of structure-based deep learning techniques in antigen specific immunotherapy design.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
